DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Vollenhoven van R F, Ernestam S, Geborek P. et al.
Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial.
Lancet 2009; 374: 459-466
We do not assume any responsibility for the contents of the web pages of other providers.